Baranowska-Jaźwiecka Anna Iza, Mianowska Beata, Fendler Wojciech, Pomykała Agnieszka, Młynarski Wojciech
Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University, Łódź, Poland, Poland.
Department of Biostatistics and Translational Medicine, Medical University of Lodz, Poland.
Pediatr Endocrinol Diabetes Metab. 2016;22(2):48-53. doi: 10.18544/PEDM-22.02.0050.
Glycated hemoglobin (HbA1c) is used as a cumulative estimate of mean blood glucose levels from the preceding 5-12 weeks. This is the gold standard in assessing glycemic control in patients with diabetes. The ADA criteria for the diagnosis of diabetes, including HbA1c level, contribute to the importance of recognizing any variation pertaining to the HbA1c measurement. HbA1c is often used as a primary endpoint in the interventional studies among patients with diabetes. Thus, knowledge about factors independently to glycemia, affecting HbA1c is clinically useful.
Evaluation variability of fetal hemoglobin (HbF) level among Polish children with diabetes and how it may affect the HbA1c level measurement.
This was a prospective cohort study. A laboratory HbA1c testing was performed for more than 96% of pediatric diabetic patients in the region. In our study we included all consecutive patients aged 2 to 18 years with type 1 diabetes (T1D) and the disease duration longer than one year (555 patients). All patients had HbA1c and HbF measured at three time-points during minimum one-year period. In the same time, clinical data were recorded. The measurements of HbA1c and HbF were performed by means of cation-exchange high-pressure liquid chromatography (HPLC) on a D-10 Dual A2/F/A1c (Bio-Rad Laboratories, Hercules, CA, USA). Statistical analysis was performed using the Statistica 10.0 package (StatSoft, Tulsa, USA).
An average age in the observed group was 12.9±3.8 years, diabetes duration 5.6±3.4 years, HbA1c was 7.59±1.33% (59±10.65 mmol/mol). In 78 (14%) patients elevated levels of HbF (>0.8%) were found at each time-point, mean value 1.2±0.45%. Elevated HbF was associated with younger age at examination (p=0.03) and younger age of diagnosis (p=0.01). It was not related to diabetes duration (p=0.21). No correlation between HbA1c and HbF was observed in the study (R=-0.09; p=0.43).
Fetal hemoglobin does not affect HbA1c measurement among pediatric patients with type 1 diabetes older that 2 years.
糖化血红蛋白(HbA1c)用于累积评估前5至12周的平均血糖水平。这是评估糖尿病患者血糖控制的金标准。美国糖尿病协会(ADA)的糖尿病诊断标准,包括HbA1c水平,凸显了认识与HbA1c测量相关的任何差异的重要性。HbA1c常被用作糖尿病患者干预性研究的主要终点。因此,了解独立于血糖水平、影响HbA1c的因素具有临床实用价值。
评估波兰糖尿病儿童中胎儿血红蛋白(HbF)水平的变异性及其对HbA1c水平测量的影响。
这是一项前瞻性队列研究。该地区超过96%的儿科糖尿病患者接受了实验室HbA1c检测。我们的研究纳入了所有年龄在2至18岁、患有1型糖尿病(T1D)且病程超过一年的连续患者(555例)。所有患者在至少一年的时间内的三个时间点测量了HbA1c和HbF。同时,记录临床数据。HbA1c和HbF的测量采用阳离子交换高压液相色谱法(HPLC),使用D-10 Dual A2/F/A1c仪器(美国加利福尼亚州赫拉克勒斯市伯乐公司)。使用Statistica 10.0软件包(美国塔尔萨市StatSoft公司)进行统计分析。
观察组的平均年龄为12.9±3.8岁,糖尿病病程为5.6±3.4年,HbA1c为7.59±1.33%(59±10.65 mmol/mol)。在78例(14%)患者中,每次测量时均发现HbF水平升高(>0.8%),平均值为1.2±0.45%。HbF升高与检查时年龄较小(p=0.03)和诊断时年龄较小(p=0.01)相关。与糖尿病病程无关(p=0.21)。研究中未观察到HbA1c与HbF之间存在相关性(R=-0.09;p=0.43)。
2岁以上的1型糖尿病儿科患者中,胎儿血红蛋白不影响HbA1c测量。